Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4112 publications

Healthcare cost comparison between first-line ibrutinib and acalabrutinib in chronic lymphocytic leukemia patients in the Veterans Affairs.

Healthcare cost comparison between first-line ibrutinib and acalabrutinib in chronic lymphocytic leukemia patients in the Veterans Affairs.

Journal: Journal of comparative effectiveness research
Published: October 14, 2025

First-line treatment of elderly patients with CLL: An innovative, chemo-free approach

First-line treatment of elderly patients with CLL: An innovative, chemo-free approach

Journal: Deutsche medizinische Wochenschrift (1946)
Published: October 10, 2025

Pirtobrutinib in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma.

Pirtobrutinib in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma.

Journal: Future oncology (London, England)
Published: October 03, 2025

Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study.

Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study.

Journal: Italian journal of dermatology and venereology
Published: October 03, 2025

Comparative study on the inhibitory potential of anticancer drugs and natural compounds against PHB proteins.

Comparative study on the inhibitory potential of anticancer drugs and natural compounds against PHB proteins.

Journal: Natural product research
Published: September 29, 2025

Zanubrutinib in the treatment of Waldenström Macroglobulinemia.

Zanubrutinib in the treatment of Waldenström Macroglobulinemia.

Journal: Future oncology (London, England)
Published: September 11, 2025

Real-world treatment patterns of Bruton tyrosine kinase inhibitors in mantle cell lymphoma in a community oncology setting.

Real-world treatment patterns of Bruton tyrosine kinase inhibitors in mantle cell lymphoma in a community oncology setting.

Journal: Future oncology (London, England)
Published: September 08, 2025

Mucorales Endocarditis: A Case Series and Review of the Literature.

Mucorales Endocarditis: A Case Series and Review of the Literature.

Journal: Cardiology in review
Published: September 05, 2025

Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis

Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 03, 2025

Ibrutinib inhibits the replication of multiple poxviruses by targeting the Bruton tyrosine kinase.

Ibrutinib inhibits the replication of multiple poxviruses by targeting the Bruton tyrosine kinase.

Journal: Journal of virology
Published: August 20, 2025

Correction: Ibrutinib as treatment for Bing-Neel syndrome reclassified as glioblastoma: a case report.

Correction: Ibrutinib as treatment for Bing-Neel syndrome reclassified as glioblastoma: a case report.

Journal: Journal of medical case reports
Published: August 19, 2025

Pirtobrutinib in Chronic Lymphocytic Leukemia: Navigating Resistance and the Personalisation of BTK-Targeted Therapy.

Pirtobrutinib in Chronic Lymphocytic Leukemia: Navigating Resistance and the Personalisation of BTK-Targeted Therapy.

Journal: Cancers
Published: August 15, 2025
Showing 1-12 of 4,112

Last Updated: 10/31/2025